CTSO
CTSO
NASDAQ · Health Care

Cytosorbents Corp

$0.55
-0.01 (-2.49%)
As of Apr 1, 3:41 PM ET ·
Financial Highlights (FY 2026)
Revenue
42.49M
Net Income
-24,731,834
Gross Margin
70.6%
Profit Margin
-58.2%
Rev Growth
-6.2%
D/E Ratio
1.26
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 70.6% 70.6% 39.9% 39.9%
Operating Margin -47.2% -42.4% 7.7% 9.4%
Profit Margin -58.2% -55.3% 5.8% 6.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 42.49M 45.31M 13.44M 11.40M
Gross Profit 29.99M 31.99M 5.36M 4.54M
Operating Income -20,038,844 -19,233,187 1.03M 1.07M
Net Income -24,731,834 -23,737,496 783.9K 740.1K
Gross Margin 70.6% 70.6% 39.9% 39.9%
Operating Margin -47.2% -42.4% 7.7% 9.4%
Profit Margin -58.2% -55.3% 5.8% 6.5%
Rev Growth -6.2% -6.2% -9.4% -6.3%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 10.50M 10.50M 11.74M 10.77M
Total Equity 8.34M 8.34M 22.15M 20.33M
D/E Ratio 1.26 1.26 0.53 0.53
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,162,238 -18,400,475 1.54M 1.35M
Free Cash Flow 1.21M 903.7K